# A Study to Evaluate the Safety of Exposure to Wegovy During Pregnancy

> **NCT05503927** · — · ENROLLING_BY_INVITATION · sponsor: **Novo Nordisk A/S** · enrollment: 1139 (estimated)

## Conditions studied

- Pregnancy
- Obesity
- Overweight

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT05503927
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-01-02
- **Primary completion:** 2027-08-15
- **Final completion:** 2027-08-15
- **Target enrollment:** 1139 (ESTIMATED)
- **Last updated:** 2026-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05503927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05503927, "A Study to Evaluate the Safety of Exposure to Wegovy During Pregnancy". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05503927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*